ProQR Therapeutics N.V. (PRQR)
NASDAQ·Healthcare·Biotechnology
$1.49
-0.34%
Mkt Cap $199.10M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 12, 2026 | $6.63M | $5.53M | -16.56% | -$0.08 | -$0.09 | -12.50% | — | — |
| Q4 2025 Nov 6, 2025 | $6.12M | $3.41M | -44.20% | -$0.10 | -$0.12 | -20.00% | — | — |
| Q3 2025 Aug 7, 2025 | $5.49M | $4.49M | -18.16% | -$0.08 | -$0.14 | -75.00% | — | — |
| Q2 2025 May 8, 2025 | $4.80M | $4.95M | +3.10% | -$0.09 | -$0.11 | -22.22% | — | — |
| Q1 2025 Mar 13, 2025 | $5.45M | $4.46M | -18.10% | -$0.10 | -$0.10 | +0.00% | — | — |
| Q4 2024 Nov 7, 2024 | $7.00M | $4.21M | -39.81% | -$0.12 | -$0.11 | +8.33% | — | — |
| Q3 2024 Aug 8, 2024 | $12.04M | $6.81M | -43.41% | -$0.12 | -$0.03 | +75.00% | — | — |
| Q2 2024 May 9, 2024 | $2.82M | $4.81M | +70.48% | -$0.12 | -$0.10 | +16.67% | — | — |
| Q1 2024 Mar 13, 2024 | $17.43M | $3.52M | -79.81% | -$0.08 | -$0.08 | +0.00% | — | — |
| Q4 2023 Nov 7, 2023 | $12.66M | $1.45M | -88.59% | -$0.06 | -$0.08 | -33.33% | — | — |
| Q3 2023 Aug 3, 2023 | $1.71M | $1.31M | -23.13% | -$0.12 | -$0.11 | +8.33% | — | — |
| Q2 2023 May 16, 2023 | $1.42M | $712.12K | -49.85% | -$0.12 | -$0.12 | +0.00% | — | — |
| Q1 2023 Mar 29, 2023 | $1.02M | $885.43K | -13.19% | -$0.20 | -$0.16 | +20.00% | — | — |
| Q4 2022 Nov 9, 2022 | $822.20K | $933.60K | +13.55% | -$0.23 | -$0.34 | -47.83% | — | — |
| Q3 2022 Aug 4, 2022 | $905.28K | $1.07M | +18.44% | -$0.26 | -$0.22 | +15.38% | — | — |
| Q2 2022 May 5, 2022 | $888.19K | $1.36M | +53.68% | -$0.25 | -$0.22 | +12.00% | — | — |
| Q1 2022 Feb 24, 2022 | $857.90K | $270.96K | -68.42% | -$0.26 | -$0.30 | -15.38% | — | — |
| Q4 2021 Nov 4, 2021 | $280.00K | $1.01M | +261.47% | -$0.23 | -$0.26 | -13.04% | — | — |
| Q3 2021 Aug 5, 2021 | $240.00K | $288.31K | +20.13% | -$0.26 | -$0.29 | -11.54% | — | — |
| Q2 2021 May 6, 2021 | $920.00K | — | — | -$0.28 | -$0.30 | -7.14% | — | — |